文献速递泌尿生殖技术与安全MR

人工智能辅助前列腺癌诊断:影像-病理对照

Artificial Intelligence-assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation.
PubMed 文献 · Radiographics · 2021-01-01

本文综述了当前前列腺癌诊断路径,重点讨论mpMRI和MRI靶向活检的作用及局限性,并概述人工智能在影像与病理图像分析中的应用前景,旨在通过整合影像-病理系统和决策支持工具提高诊断准确性和效率。

要点

  • mpMRI和MRI靶向活检已广泛用于前列腺癌诊断,但仍存在局限性。
  • Gleason分级主观且可重复性差,活检与根治标本病理存在差异。
  • 人工智能可辅助影像与病理图像分析,改善诊断准确性和效率。

局限性

  • mpMRI和MRI靶向活检仍存在局限性。
  • Gleason分级主观且可重复性差,活检与根治标本病理存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The classic prostate cancer (PCa) diagnostic pathway that is based on prostate-specific antigen (PSA) levels and the findings of digital rectal examination followed by systematic biopsy has shown multiple limitations. The use of multiparametric MRI (mpMRI) is now widely accepted in men with clinical suspicion for PCa. In addition, clinical information, PSA density, risk calculators, and genomic and other "omics" biomarkers are being used to improve risk stratification. On the basis of mpMRI and MRI-targeted biopsies (MRI-TBx), new diagnostic pathways have been established, aiming to improve the limitations of the classic diagnostic approach. However, these pathways still show limitations associated with mpMRI and MRI-TBx. Definitive PCa diagnosis is made on the basis of histopathologic Gleason grading, which has demonstrated an excellent correlation with clinical outcomes. However, Gleason grading is done subjectively by pathologists and involves poor reproducibility, and PCa may have a heterogeneous distribution of histologic patterns. Thus, important discrepancies persist between biopsy tumor grading and final whole-organ pathologic assessment after radical prostatectomy. PCa offers a unique opportunity to establish a real radiologic-pathologic correlation, as whole-mount radical prostatectomy specimens permit a complete spatial relationship with mpMRI. Artificial intelligence is increasingly being applied to radiologic and pathologic images to improve clinical accuracy and efficiency in PCa diagnosis. This review delineates current PCa diagnostic pathways, with a focus on the role of mpMRI, MRI-TBx, and pathologic analysis. An overview of the expected improvements in PCa diagnosis derived from the use of artificial intelligence, integrated radiologic-pathologic systems, and decision support tools for multidisciplinary teams is provided. An invited commentary by Purysko is available online. Online supplemental material is available for this article. ©RSNA, 2021.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Mata LA, Retamero JA, Gupta RT, et al. Artificial Intelligence-assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation. Radiographics. 2021. PMID: 34597215. doi:10.1148/rg.2021210020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。